CMS Open Payments · Program Year 2024
B. Braun Medical Inc.
B. Braun Medical Inc. reported $221,227.18 across General Payments, Research, and Ownership to 87 physicians and teaching hospitals across 87 transactions.
- $221.2K
- All-tracks total
- 87
- Transactions
- 87
- Recipients
- +$130.7K
- General Payments vs PY2023
B. Braun Medical Inc. reported $221,227.18 across all CMS Open Payments tracks (General + Research + Ownership) to 87 physicians and teaching hospitals in Program Year 2024 - ranking #976 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $221,227.18, averaging $2.5K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer b-braun-medical-inc B. Braun Medical Inc.
$221.2K · #976/1,925 · 0.0% industry · PY2024
- TOT $221.2K
- RANK #976
- SHARE 0.0%
- TXN 87
- RCP 87
- CAT 6
- GEN $221.2K
- ΔGEN +$130.7K
- TOP1 16.2%
- PY 2024
Volume peers
Nearest volume peer: Kyowa Kirin Services Ltd ($221.8K)
B. Braun Medical Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
B. Braun Medical Inc.'s CMS-reported General Payments increased by $130.7K (+144.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: B. BRAUN MEDICAL INC.PY2023: B. BRAUN MEDICAL INC.PY2024: B. Braun Medical Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $90,562.92
- PY2024
- $221,227.18
What the Data Shows for B. Braun Medical Inc.
Averaging $2.5K per transaction and $2.5K per recipient, B. Braun Medical Inc.'s Program Year 2024 total comes to $221,227.18 across 87 transactions and 87 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #976 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
The 6-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Debt Forgiveness" at $123.1K, accounting for 55.7% of this company's General Payments and 19 transactions.
General Payment Breakdown by Type
"Debt Forgiveness" leads B. Braun Medical Inc.'s 6-category general-payment breakdown at $123.1K, 55.7% of the reported total.
B. Braun Medical Inc. reports 6 general-payment categories - the top three are Debt Forgiveness (55.7%), Charitable Contribution (27.1%), and Consulting Fee (13.6%). The remaining 3 categories make up 3.6% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How B. Braun Medical Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Debt Forgiveness | $123.1K | 19 | 55.7% |
| Charitable Contribution | $60.0K | 2 | 27.1% |
| Consulting Fee | $30.1K | 9 | 13.6% |
| Grant | $4.0K | 2 | 1.8% |
| Travel and Lodging | $2.5K | 8 | 1.1% |
| Food and Beverage | $1.5K | 47 | 0.7% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $141,341.37 (63.9%) of $221,227.18 in this company's General Payments records across 69 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for B. Braun Medical Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Northshore University Healthsystem
$35,794.60 across 1 reported transactions
- 2
Lehigh Valley
$30,000.00 across 1 reported transactions
- 3
St. Lukes Hospital
$30,000.00 across 1 reported transactions
- 4
St Christophers Hospital for Childr
$27,325.17 across 1 reported transactions
- 5
St Joseph Medical Center
$18,221.60 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as B. Braun Medical Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about B. Braun Medical Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with B. Braun Medical Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Evologics LLC
Bioprotect Ltd.
Joimax, Inc.
FHC, Inc.
Fisher & Paykel Healthcare Inc
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.